Company Overview

Update
Founded:
1987
Headquarters:
Foster City, CA
IPO:
Went Public on Jan 31, 1992
Stock:
GILD
Categories:
Biotechnology
Description:
Gilead Sciences is a biopharmaceutical company that discovers, develops, manufactures and commercializes therapies for critical diseases.

Detailed Description

Update

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet need. With each new discovery and experimental drug candidate, they seek to improve the care of patients suffering from life-threatening diseases.

Gilead’s primary areas of focus include HIV/AIDS, liver disease and serious cardiovascular and respiratory conditions.

There portfolio of 13 marketed products includes a number of category firsts and market leaders, including Atripla® (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg) - the first single-tablet regimen for HIV infection. The company’s first product for HIV infection, Viread® (tenofovir disoproxil fumarate), has also more recently been approved for the treatment of chronic hepatitis B. Chronic hepatitis B, a serious liver disease caused by the hepatitis B virus, is the leading cause of liver cancer worldwide and affects an estimated two million individuals in the United States.

Current Team (9)

Update
  • Cf067700919d5a32faa9fe016dc77362

    John C. Martin

    Chairman and CEO, President and Chief Executive Officer
    1990
  • F268650e27c655ed235c745395b114af

    Mark Chin

    Corporate Development
  • Fd7decde9a50ea30d201de4dadf4a2ea

    John F. Milligan

    President and COO,Chief Financial Officer, Director of Project Management and Project Team Leader
    1990
  • 32ef492405ac878987a894c292a7eca0

    Gregg H. Alton

    Executive Vice President, Corporate and Medical Affairs, General Counsel, Associate General Counsel, Attorney
    1999
  • E6e1579e211476cdb82808a8100c449e

    Robin L. Washington

    Senior Vice President and Chief Financial Officer
    2008
  • 3808ca993afc0c5b45d74ce84b2967eb

    Katie L. Watson

    Senior Vice President, Human Resources
    2012
  • Cb default image

    Bill Lee

    Senior Vice President Research
  • A1ed355821d5ccda526e13468c33af7d

    Norbert W. Bischofberger

    Executive Vice President, Research and Development and Chief Scientific Officer
    1990

Past Team (33)

Update

Board Members and Advisors (2)

Update

Acquisitions (3)

Update

Offices/Locations (1)

Update
  • Office

    333 Lakeside Drive

    Foster City, CA 94404

    USA

Images (1)

Update
  • Cufcyov8gxiwubfz3vul